| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.70▲ | 2.69▲ | 2.69▲ | 2.79▼ | 2.44▲ |
| MA10 | 2.70▲ | 2.69▲ | 2.74▼ | 2.58▲ | 2.67▲ |
| MA20 | 2.70▲ | 2.75▼ | 2.82▼ | 2.51▲ | 2.02▲ |
| MA50 | 2.69▲ | 2.85▼ | 2.61▲ | 2.58▲ | 1.67▲ |
| MA100 | 2.75▼ | 2.60▲ | 2.54▲ | 2.00▲ | 3.13▼ |
| MA200 | 2.83▼ | 2.53▲ | 2.48▲ | 1.74▲ | 12.18▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.003▼ | -0.033▼ | 0.042▲ | 0.043▲ |
| RSI | 59.886▲ | 43.570▼ | 47.369▼ | 54.534▲ | 60.158▲ |
| STOCH | 43.333 | 28.585 | 13.297▼ | 70.438 | 39.096 |
| WILL %R | 0.000▲ | -71.053 | -78.431▼ | -40.777 | -46.970 |
| CCI | 96.000 | -26.381 | -74.249 | 77.669 | 51.318 |
|
Wednesday, February 18, 2026 12:00 AM
SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 ...
|
|
Tuesday, February 03, 2026 08:05 AM
SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 ...
|
|
Monday, November 24, 2025 02:52 AM
Zentalis Pharmaceuticals (ZNTL) is focused on developing azenosertib, a WEE1 inhibitor, for platinum-resistant ovarian cancer, with a pivotal DENALI Phase 2 trial ongoing. ZNTL stock has fallen over ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/03/26 | 2.86 | 2.86 | 2.66 | 2.71 | 396,779 |
| 12/03/26 | 2.88 | 2.90 | 2.74 | 2.75 | 563,295 |
| 11/03/26 | 3.06 | 3.13 | 2.85 | 2.96 | 889,836 |
| 10/03/26 | 2.48 | 3.11 | 2.4501 | 3.06 | 2,075,669 |
| 09/03/26 | 2.25 | 2.515 | 2.25 | 2.48 | 518,598 |
| 06/03/26 | 2.16 | 2.32 | 2.10 | 2.295 | 612,634 |
| 05/03/26 | 2.47 | 2.47 | 2.14 | 2.185 | 1,445,916 |
| 04/03/26 | 2.44 | 2.555 | 2.35 | 2.51 | 479,478 |
| 03/03/26 | 2.41 | 2.46 | 2.334 | 2.38 | 390,269 |
| 02/03/26 | 2.35 | 2.505 | 2.35 | 2.50 | 373,844 |
|
|
||||
|
|
||||
|
|